BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 20708346)

  • 1. Clinical outcomes of intensity-modulated pelvic radiation therapy for carcinoma of the cervix.
    Hasselle MD; Rose BS; Kochanski JD; Nath SK; Bafana R; Yashar CM; Hasan Y; Roeske JC; Mundt AJ; Mell LK
    Int J Radiat Oncol Biol Phys; 2011 Aug; 80(5):1436-45. PubMed ID: 20708346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Definitive intensity-modulated radiation therapy with concurrent chemotherapy for patients with locally advanced cervical cancer.
    Chen CC; Lin JC; Jan JS; Ho SC; Wang L
    Gynecol Oncol; 2011 Jul; 122(1):9-13. PubMed ID: 21514629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Helical tomotherapy with simultaneous integrated boost after laparoscopic staging in patients with cervical cancer: analysis of feasibility and early toxicity.
    Marnitz S; Köhler C; Burova E; Wlodarczyk W; Jahn U; Grün A; Budach V; Stromberger C
    Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):e137-43. PubMed ID: 21600704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intensity-modulated radiation therapy for advanced cervical cancer: a comparison of dosimetric and clinical outcomes with conventional radiotherapy.
    Du XL; Tao J; Sheng XG; Lu CH; Yu H; Wang C; Song QQ; Li QS; Pan CX
    Gynecol Oncol; 2012 Apr; 125(1):151-7. PubMed ID: 22198339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjuvant concurrent chemoradiotherapy with intensity-modulated pelvic radiotherapy after surgery for high-risk, early stage cervical cancer patients.
    Chen MF; Tseng CJ; Tseng CC; Yu CY; Wu CT; Chen WC
    Cancer J; 2008; 14(3):200-6. PubMed ID: 18536561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: an update of radiation therapy oncology group trial (RTOG) 90-01.
    Eifel PJ; Winter K; Morris M; Levenback C; Grigsby PW; Cooper J; Rotman M; Gershenson D; Mutch DG
    J Clin Oncol; 2004 Mar; 22(5):872-80. PubMed ID: 14990643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Split-field helical tomotherapy with or without chemotherapy for definitive treatment of cervical cancer.
    Chang AJ; Richardson S; Grigsby PW; Schwarz JK
    Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):263-9. PubMed ID: 21167656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiation therapy and simultaneous chemotherapy for recurrent cervical carcinoma.
    Windschall A; Ott OJ; Sauer R; Strnad V
    Strahlenther Onkol; 2005 Aug; 181(8):545-50. PubMed ID: 16044224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical outcome of adjuvant treatment of endometrial cancer using aperture-based intensity-modulated radiotherapy.
    Bouchard M; Nadeau S; Gingras L; Raymond PE; Beaulieu F; Beaulieu L; Fortin A; Germain I
    Int J Radiat Oncol Biol Phys; 2008 Aug; 71(5):1343-50. PubMed ID: 18294780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined intensity-modulated radiation therapy and brachytherapy in the treatment of cervical cancer.
    Macdonald DM; Lin LL; Biehl K; Mutic S; Nantz R; Grigsby PW
    Int J Radiat Oncol Biol Phys; 2008 Jun; 71(2):618-24. PubMed ID: 18407429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Intensity modulated radiation therapy for patients with gynecological malignancies after hysterectomy and chemotherapy/radiotherapy].
    Chen ZY; Ma YB; Sheng XG; Zhang XL; Xue L; Song QQ; Liu NF; Miao HQ
    Zhonghua Zhong Liu Za Zhi; 2007 Apr; 29(4):305-8. PubMed ID: 17760262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiotherapy doses at special reference points correlate with the outcome of cervical cancer therapy.
    Yoshimura R; Hayashi K; Ayukawa F; Toda K; Iwata M; Oota S; Hoshi A; Wakatsuki M; Kurosaki H; Okazaki A; Shibuya H
    Brachytherapy; 2008; 7(3):260-6. PubMed ID: 18579445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Preoperative concurrent radiation therapy and chemotherapy for operable bulky carcinomas of uterine cervix stages IB2, IIA, and IIB with proximal parametrial invasion].
    Lerouge D; Touboul E; Lefranc JP; Uzan S; Jannet D; Moureau-Zabotto L; Genestie C; Antoine M; Jamali M
    Cancer Radiother; 2004 Jun; 8(3):168-77. PubMed ID: 15217584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical outcome in posthysterectomy cervical cancer patients treated with concurrent Cisplatin and intensity-modulated pelvic radiotherapy: comparison with conventional radiotherapy.
    Chen MF; Tseng CJ; Tseng CC; Kuo YC; Yu CY; Chen WC
    Int J Radiat Oncol Biol Phys; 2007 Apr; 67(5):1438-44. PubMed ID: 17394944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Preliminary study of intensity-modulated radiation therapy for recurrent cervical cancer].
    Zhou Q; Tang Y; Shu XL; Liu L
    Zhonghua Fu Chan Ke Za Zhi; 2007 Nov; 42(11):730-2. PubMed ID: 18307896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stage-adjusted chemoradiation in cervical cancer after transperitoneal laparoscopic staging.
    Marnitz S; Köhler C; Roth C; Füller J; Bischoff A; Wendt T; Schneider A; Budach V
    Strahlenther Onkol; 2007 Sep; 183(9):473-8. PubMed ID: 17762920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A dosimetric analysis of intensity-modulated radiation therapy (IMRT) as an alternative to adjuvant high-dose-rate (HDR) brachytherapy in early endometrial cancer patients.
    Aydogan B; Mundt AJ; Smith BD; Mell LK; Wang S; Sutton H; Roeske JC
    Int J Radiat Oncol Biol Phys; 2006 May; 65(1):266-73. PubMed ID: 16618581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dosimetric predictors of acute hematologic toxicity in cervical cancer patients treated with concurrent cisplatin and intensity-modulated pelvic radiotherapy.
    Mell LK; Kochanski JD; Roeske JC; Haslam JJ; Mehta N; Yamada SD; Hurteau JA; Collins YC; Lengyel E; Mundt AJ
    Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1356-65. PubMed ID: 16757127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Locally advanced cervical cancer: Should intensity-modulated radiotherapy replace brachytherapy?].
    Mazeron R; Gilmore J; Khodari W; Dumas I; Haie-Méder C
    Cancer Radiother; 2011 Oct; 15(6-7):477-83. PubMed ID: 21880534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiation-related predictors of hematologic toxicity after concurrent chemoradiation for cervical cancer and implications for bone marrow-sparing pelvic IMRT.
    Albuquerque K; Giangreco D; Morrison C; Siddiqui M; Sinacore J; Potkul R; Roeske J
    Int J Radiat Oncol Biol Phys; 2011 Mar; 79(4):1043-7. PubMed ID: 20471182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.